GGrantIndex
← Leaderboards

Nicole K Paulk

Oregon Health & Science University

$1,083,618
Attributed
$1,083,618
Total exposure
3
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $165.2K · FY200720
$200K$150K$100K$50K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20

Funding mix

By agency

NIH$1,083,618 · 3

By mechanism

K01$782,093 · 1
F31$182,417 · 1
F32$119,108 · 1

Top collaborators

No co-investigators on record.

Most similar at Oregon Health & Science University

Same institution · by research overlap

Others in their field

Top investigators on “Tissues

Research focus

TissuesHepatocyteLiverMetabolicIn VivoUnited States National Institutes Of HealthAffectLiver DiseasesTherapeutic GeneCellsMethodologyPre-ClinicalPropertySerotypingPreventCapsidAnimal ModelLibrariesGene TherapyEventClinical TrialsDependovirusIn VitroTrafficking

Grant awards (13)

Overcoming sexually dimorphic barriers to viral gene therapy for treating genetic liver diseases$157,569
K01 · FY2020 · DK · contact PI
Overcoming sexually dimorphic barriers to viral gene therapy for treating genetic liver diseases$157,569
K01 · FY2019 · DK · contact PI
Overcoming sexually dimorphic barriers to viral gene therapy for treating genetic liver diseases$157,569
K01 · FY2018 · DK · contact PI
Overcoming sexually dimorphic barriers to viral gene therapy for treating genetic liver diseases.$153,943
K01 · FY2017 · DK · contact PI
Overcoming sexually dimorphic barriers to viral gene therapy for treating genetic liver diseases.$155,443
K01 · FY2016 · DK · contact PI
Novel strategies to expand the adeno-associated virus platform.$9,784
F32 · FY2016 · HL · contact PI
Novel strategies to expand the adeno-associated virus platform.$56,042
F32 · FY2015 · HL · contact PI
Novel strategies to expand the adeno-associated virus platform.$53,282
F32 · FY2014 · HL · contact PI
Determining the Progenitor-Like Capacity of Liver Cancer Cells in vivo.$33,262
F31 · FY2011 · CA · contact PI
Determining the Progenitor-Like Capacity of Liver Cancer Cells in vivo.$41,380
F31 · FY2010 · CA · contact PI
Determining the Progenitor-Like Capacity of Liver Cancer Cells in vivo.$40,300
F31 · FY2009 · CA · contact PI
Determining the Progenitor-Like Capacity of Liver Cancer Cells in vivo.$38,721
F31 · FY2008 · CA · contact PI
Determining the Progenitor-Like Capacity of Liver Cancer Cells in vivo.$28,754
F31 · FY2007 · CA · contact PI